- Key Takeaways
- Effective denial management services combine five pillars – prevention, root-cause analytics, appeal velocity, targeted automation, and specialty depth – to protect the 5–11% of net revenue providers lose to denials.
- Hospitals spent $43 billion in 2025 chasing payments from insurers for care already delivered, and administrative work now consumes more than 40% of total cost of care.
- Denial management is the discipline of preventing, categorizing, appealing, and root-causing claim denials inside the broader revenue cycle, so providers keep more of what they have already earned.
- A good claim denial rate sits below 5% on first submission, according to MGMA benchmarks; the median across single-specialty practices runs closer to 8%, and rising.
- Neolytix earned a spot on Becker’s 2026 RCM Companies to Know list by delivering clean claim rates above 96%, A/R under 60 days, and 40%+ denial reductions.
Featured on Becker’s Healthcare 2026 Revenue Cycle Management Companies to Know — a closer look at why claim denials are escalating, what providers are doing about it, and how Neolytix helps protect the 5–11% of net revenue that denials quietly drain every year.
A Quiet Crisis That Costs U.S. Providers $262 Billion a Year
When Becker’s Healthcare released its 2026 Revenue Cycle Management Companies to Know list, it spotlighted the organizations helping U.S. healthcare providers recover revenue and rebuild financial resilience in one of the most punishing reimbursement environments in modern memory. We’re proud that Neolytix was named to that list — alongside a roster of innovators tackling the same underlying problem: every year, up to $262 billion in U.S. healthcare claims are denied on first submission. That number is more than a headline. It represents care delivered, services already rendered, and revenue that providers have to fight — sometimes for months — to recover.
The Scale of the Denial Problem in 2026
ound that MA plans denied 17% of initial claim submissions. While 57% of those denials were eventually overturned on appeal, providers absorbed a 7% net revenue reduction on the dollar-weighted share that wasn’t recovered — plus weeks of administrative work to get there. On the commercial side, KFF’s 2023 analysis of ACA marketplace plans found that roughly 1 in 5 adults covered by employer-sponsored or marketplace insurance reported having a claim denied — compared with about 1 in 10 Medicare enrollees.
“The most frequent denial reason in 2023 wasn’t a coverage exclusion or a medical necessity dispute. It was ‘other,’ followed by administrative issues. In other words, the largest single bucket of denied healthcare revenue is process — not policy.”
Why Claim Denials Are Climbing
Five forces are converging to push denial rates higher in 2026:
- Prior authorization surges. The American Hospital Association reports that Medicare Advantage insurers alone issued nearly 53 million prior authorization determinations in 2024 — about 1.7 per enrollee — and the share that providers had to appeal rose from 7.5% in 2019 to 11.5% in 2024.
- Payer edit complexity. Edits, modifiers, and bundling rules now change faster than most billing systems can keep up. The result: more first-pass rejections that have nothing to do with the underlying care.
- Documentation gaps. Clinical documentation that satisfied a payer in 2022 increasingly fails medical-necessity review in 2026 — a pattern we explore in Top 10 Denials in Medical Billing.
- Eligibility & coverage churn. Post-PHE Medicaid redeterminations and rising commercial plan turnover mean eligibility verified at scheduling is often stale by the date of service.
- Workforce strain. AHA data shows the average U.S. hospital now employs roughly 64 administrative and billing staff dedicated to insurer interactions — yet RCM teams still report being understaffed for the volume of denials and appeals.
The compound effect: the AHA estimates that hospitals spent $43 billion in 2025 alone trying to collect payments from insurers for care already delivered, and administrative costs now exceed 40% of the total cost of delivering care. For physician practices, MGMA benchmarks put the median first-submission denial rate at around 8%, while best-in-class groups hold theirs below 5%.
- Neolytix • RCM
Revenue Cycle Management
The Hidden Cost Most Providers Underestimate
Denials don’t just cost the value of the denied claim. They generate four downstream costs that rarely show up on a P&L line:
- Rework expense. Industry estimates put the cost of reworking a single denied claim between $25 and $118 depending on complexity.
- Cash-flow drag. Each denial extends days in A/R, tightens working capital, and increases the cost of bridging cash gaps with credit lines.
- Write-off leakage. Roughly 65% of denied claims are never resubmitted at all — they’re written off as a loss because teams don’t have capacity to chase them.
- Patient experience erosion. Denials become surprise bills, balance-billing disputes, and friction at the front desk — eroding trust precisely when retention matters most.
This is the gap a modern denial management program is built to close — and it’s where Neolytix focuses its work.
What Effective Denial Management Services Look Like
There is no single dashboard, AI tool, or vendor that solves denials by itself. The providers winning this battle are the ones who treat denial management as an end-to-end discipline rather than a back-office cleanup function. Effective programs share five characteristics:
- Prevention before recovery
More than 85% of denials are preventable. That means the highest-ROI work happens before the claim is submitted — in front-end eligibility verification, prior authorization workflow, charge capture, and coding integrity. See our breakdown in Clean Claim in Medical Billing: Definition, Rate & Best Practices.
- Root-cause analytics, not just reason codes
Counting CARC and RARC codes is table stakes. The real win is mapping denials back to the operational source — a specific scheduler, a specific payer policy, a specific provider, a specific CPT pairing — and fixing the upstream process. Our Healthcare Revenue Cycle Metrics (KPIs) to Stop Revenue Leakage guide details the metrics that actually move the dial.
- Appeal velocity
When the Premier Inc. national hospital survey found that roughly 70% of denied claims are eventually paid after appeal, it confirmed what every RCM director already suspects: most denials are wrong. The financial question is how fast you can prove it. Programs that compress appeal cycles from 60+ days to under 21 days recover dramatically more revenue per FTE. See How to Appeal a Medical Billing Denial & Recover Lost Revenue.
- Automation in the right places
Robotic process automation, payer-portal bots, and AI-assisted documentation review work best when applied to the highest-volume, lowest-judgment tasks — eligibility checks, status follow-ups, and denial categorization — freeing experienced staff to handle complex appeals. Learn more about our approach in Healthcare Automation.
- Specialty depth
Behavioral health denials don’t look like sleep medicine denials, and neither looks like orthopedics or cardiology. Effective denial management requires specialty-specific playbooks, coder expertise, and payer-policy intelligence that generalist vendors rarely maintain.
How Neolytix Is Part of the Solution
Neolytix is a Services-as-a-Software company with 14+ years of healthcare operations experience, currently serving 31 specialties across 40 states. Our end-to-end revenue cycle management platform combines U.S.-based RCM strategists, certified coders, denial-recovery specialists, and proprietary automation to deliver three outcomes our clients consistently see:
- Clean claim rates above 96% — well past the MGMA best-practice threshold.
- A/R days under 60 — across mixed payer portfolios, including Medicare Advantage and ACA marketplace plans.
- Denial rate reductions of 40% or more — typically within the first two quarters of engagement.
Two of our recent client engagements show what that looks like in practice:
Sleep diagnostic center. A multi-site sleep medicine practice was bleeding Medicare revenue on its core CPT codes (95810, 95811, 95806). Our team rebuilt documentation templates, retrained the front-end workflow, and reworked the appeals pipeline. Result: a 50% reduction in Medicare denials and an 80% first-pass resolution rate within two reporting cycles. Read the full Medicare Denial Recovery case study.
Behavioral health group. A multi-specialty behavioral health organization came to us with 6–7 month documentation delays, 71% of A/R aging beyond 30 days, and more than $16,000 in blocked Medicare payments. Neolytix re-engineered the revenue cycle from scheduling through appeals — see the behavioral health audit case study.
These outcomes aren’t accidents. They’re the product of the five-pillar discipline above, applied with negotiated payer relationships in all 50 states — including UnitedHealthcare, Anthem, Aetna, Cigna, and Humana — and an analytics layer that turns denial data into operational decisions.
Conclusion: From Recognition to Results
The $262 billion lost to denied U.S. healthcare claims every year is not a fixed cost of doing business. It is the cumulative output of preventable process failures — eligibility gaps, documentation drift, payer-edit complexity, and appeal backlogs — that compound across millions of claims annually. The providers who treat denial management as a strategic discipline, rather than an administrative afterthought, are the ones who keep the most of what they earn.
Recognition is meaningful — but the metric that matters is the one on your monthly cash report. Higher clean claim rates, faster appeal cycles, lower A/R days, and a denial trend line moving in the right direction are not aspirational outcomes. They are the standard our clients expect, and the standard a modern revenue cycle management program is built to deliver.
Further reading: Complete Guide to Denial Management in Medical Billing · Ultimate Guide to Revenue Cycle Management · 10 Revenue Cycle Management Trends Defining 2026 · Medicare Payment Cuts 2026: Survival Guide.
- Neolytix • Contact Us
Schedule a Consultation
Neolytix partners with healthcare organizations across revenue cycle, credentialing, and administrative operations ,14+ years of expertise and AI-enabled automation to reduce inefficiencies and drive sustainable growth.
Sources
Frequently Asked Questions
What does the $262 billion in denied healthcare claims figure actually represent?
It’s the estimated annual value of U.S. healthcare claims denied on first submission. Roughly 65% are never resubmitted, and the AHA reports hospitals spent $43 billion in 2025 alone trying to collect from insurers for care already delivered.
What is a good claim denial rate in 2026?
MGMA benchmarks put the median first-submission denial rate around 8%. Best-in-class practices hold theirs below 5%. Neolytix clients consistently achieve clean claim rates above 96%.
Are most denied claims actually appealable?
Yes. Premier’s national hospital survey found that roughly 70% of denied claims are eventually paid after appeal, and a Health Affairs study showed 57% of Medicare Advantage denials are overturned. Most denials are wrong — the question is appeal velocity.
What's the difference between denial management and revenue cycle management?
RCM is the full end-to-end process from scheduling to final payment. Denial management is the specialized discipline within RCM focused on preventing, categorizing, appealing, and root-causing claim denials. Strong denial management is what separates a 95%+ clean-claim RCM operation from an average one.
How quickly does a denial management program show results?
Neolytix clients typically see denial rate reductions of 40% or more within the first two reporting cycles (roughly two quarters), with most front-end fixes (eligibility, prior authorization, documentation) showing measurable lift inside 30–60 days.
